Identification of high-risk groups among node-positive patients with stage IB and IIA cervical carcinoma

Gynecologic Oncology

Volumn 64, Issue 3, 1997, Pages 463-467

  Samlal, Rahul A K ^a   Van Der Velden, Jacobus ^a   Schilthuis, Marten S ^a   González González, Dionisio ^a   Ten Kate, Fiebo J W ^a   Hart, Augustinus A M ^a   Lammes, Frits B ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INFILTRATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; REGRESSION ANALYSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; UTERINE CERVIX CARCINOMA;

EID: 0031105489     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.4576     Document Type: Article

References (31)

1. 1. Soisson AP, Soper JT, Clarke-Pearson DL, Berchuck A, Montana G, Creasman WT: Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol 37:390-395, 1990
2. 2. Hale RJ, Wilcox FL, Buckley CH, Tindall VR, Ryder WDJ, Logue JP: Prognostic factors in uterine cervical carcinoma: A clininopathological analysis. Int J Gynecol Cancer 1:19-23, 1991
3. 3. Wertheim MS, Hakes TB, Daghestani AN, Nori D, Smith DH, Lewis JL: A pilot study of adjuvant therapy in patients with cervical cancer at high risk of recurrence after radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol 3:912-916, 1985
4. 4. Killackey MA, Boardman L, Carroll DS: Adjuvant chemotherapy and radiation in patients with poor prognostic stage IB/IIA cervical cancer. Gynecol Oncol 49:377-379, 1993
5. 5. Lai C, Lin T, Soong Y, Phil M, Chen H: Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma. Gynecol Oncol 35:193-198, 1989
6. 6. Tattersall MHN, Ramirez C, Coppleson M: A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage IB-IIA cervical cancer patients with pelvic lymph node metastases. Gynecol Oncol 46:176-181, 1992
7. 7. Tinga DJ, Timmer PR, Bouma J, Aalders JG: Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage IB. Gynecol Oncol 39:175-180, 1990
8. 8. Inoue T, Morita K: The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer 65:1923-1927, 1990
9. 9. Inoue T, Okumara M: Prognostic significance of parametrial extension in patients with cervical carcinoma stages IB, IIA and IIB. Cancer 54:1714-1719, 1934
10. 10. Bleker OP, Ketting BW, van Wayjen-Eecen B, Kloosterman GJ: The significance of microscopic involvement of the parametrium and/or pelvic lymph nodes in cervical cancer stages IB and IIA. Gynecol Oncol 16:56-52, 1983
11. 11. Larson DM, Stringer A, Copeland LJ, Gershenson DM, Malone JM, Rutledge FN: Stage IB cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy: Role of adjuvant radiotherapy. Obstet Gynecol 69:378-381, 1987
12. 12. Tinga DJ, Bouma J, Aalders JG: Patients with squamous cell versus adeno(squamous) carcinoma of the cervix: What factors determine the prognosis? Int J Gynecol Cancer 2:83-91, 1994
13. 13. Martimbeau PW, Kjorstad KE, Iversen T: Stage IB carcinoma of the cervix, the Norwegian radium hospital: II. Results when pelvic nodes are involved. Obstet Gynecol 60:215-218, 1982
14. 14. Kaplan EL, Meier P: Nonparametric estamation from incomplete observations. Am Stat Assoc J 53:457-481, 1958
15. 15. Alvarez RD, Soong S, Kinney WK, Reid GC, Schray MF, Podratz KC, Morley GW, Shingleton HM: Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol 35:130-135, 1989
16. 16. Monk BJ, Cha DS, Walker JL, Burger RA, Ramsinghani NS, Manetta A, Disaia PJ, Berman ML: Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage Ib and IIa cervical carcinoma. Gynecol Oncol 54:4-9, 1994
17. 17. Gonzalez Gonzalez D, Ketting BW, van Bunningen B, van Dijk JDP: Carcinoma of the uterine cervix stage IB and IIA: Results of postoperative irradiation in patients with microscopic infiltration in the parametrium and/or lymph node metastasis. Int J Radiat Oncol Biol Phys 16:389-395, 1989
18. 18. Lai C, Chang H, Chang T, Hsueh S, Tang SG: Prognostic factors and impacts of adjuvant therapy in early-stage cervical carcinoma with pelvic node metastases. Gynecol Oncol 51:390-396, 1993
19. 19. Stock RG, Chen ASJ, Flickinger JC, Kalnicki S, Seski J: Node-positive cervical cancer: Impact of pelvic irradiation and patterns of failure. Int J Radiat Oncol Biol Phys 31:31-36, 1995
20. 20. Lee YN, Wang KL, Lin CH, et al: Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: A clinical review of 954 cases. Gynecol Oncol 32:135-142, 1993
21. 21. Delgado G, Bundy B, Zaino R, Sevin B, Creasman WT, Major FM: Prospective surgical-pathological study of disease-free interval in patients with squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol 38:352-357, 1990
22. 22. Hale RJ, Buckley CH, Wilcox FL, Tindall VR, Logue JP: The morphology and distribution of lymph node metastases in stage IB/IIA cervical carcinoma: Relation to prognosis. Int J Gynecol Cancer 1:233-237, 1991
23. 23. Samlal RAK, van der Velden J, Ketting BW, Gonzales Gonzales D, Ten Kate FJW, Hart AAW, Lammes FB: Disease-free interval and recurrence with the Okabayashi variant of Wertheim's radical hysterectomy for stage IB and IIA cervical carcinoma. Int J Gynecol Cancer 6:120-127, 1996
24. 24. Fuller AF, Elliot N, Kosloff C, Lewis JL: Lymph node metastases from carcinoma of the cervix, stages IB and IIA: Implications for prognosis and treatment. Gynecol Oncol 13:165-174, 1982
25. 25. Monaghan JM, Ireland D, Shlomo MY, Pearson SE, Lopes A, Sinha DP: Role of centralization of surgery in stage IB carcinoma of the cervix: A review of 498 cases. Gynecol Oncol 37:206-209, 1990
26. 26. Kinney WK, Alvarez RD, Reid GC, et al: Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: A matched-control study. Gynecol Oncol 34:258-262, 1989
27. 27. McLellan R, Dillon MB, Woodruff JD, et al.: Long term follow-up of stage I cervical adenocarcinoma treated by radical surgery. Gynecol Oncol 52:243-259, 1994
28. 28. Thomas GM, Dembo AJ, Myhr T, Black B, Pringle JF, Rawlings G: Long-term results of concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after surgery. Int J Gynecol Cancer 3:193-198, 1993
29. 29. Lin J, Ho ES, Jan J, Yang C, Liu F: High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix. Gynecol Oncol 61:101-108, 1996
30. 30. Sharma S, Sandher APS, Patel FD, Ghosal S, Gupta BD, Yadav NS: Side-effects of local hyperthermia: Results of a prospectively randomized clinical study. Int J Hyperthermia 6:279-285, 1990
31. 31. Rietbroek RC, Bakker PJM, Schilthuis MS, Postma AJ, Zum Vorde Sive Vording PJ, Gonzalez Gonzalez D, Kurth KH, Bakker AJ, Veenhof CHN: Feasibility, toxicity, and preliminary results of weekly loco-regional hyperthermia and cisplatinum in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer. Int J Radiat Oncol Biol Phys 34:887-893, 1996